Combat Group
  • Home
  • Healthcare Professionals
    • Urology
      • Clinical Evidence
      • BRS HIVEC Systems
      • Training Resources
      • HIVEC Clinical Trials
    • Surgical Oncology
      • Clinical Evidence
      • PRS+ HIPEC System
      • Training Resources
      • HIPEC Clinical Trials
  • Products
    • BRS HIVEC (Bladder Cancer)
    • PRS HIPEC (Peritoneal Cancers)
  • Patient Support
    • Bladder Cancer Patients HIVEC
    • Bladder Cancer Patients HIVEC Deutsch
    • Surgical Oncology Patients HIPEC
  • Global Partners
    • BRS HIVEC Distributors
    • PRS HIPEC Distributors
  • About Us
    • Company
    • News Feed
    • Investors
    • Team
      • Advisory Board
      • Board and Senior Management Team
    • Contact
  • Our Blog
  • en EN
    • en EN
    • es ES
Select Page
The Urgent Need for Early Diagnosis in Ovarian Cancer – Insights from the ROCkeTS Study

The Urgent Need for Early Diagnosis in Ovarian Cancer – Insights from the ROCkeTS Study

by Combat Cancer | Aug 30, 2024 | News

Ovarian cancer remains one of the most challenging cancers to diagnose and treat, and it has been dubbed the “silent killer” due to its subtle and often overlooked symptoms. High-grade serous ovarian cancer (HGSOC) is the most aggressive form, and...
Pancreatic Cancer – Risks, Pathology, and Treatment with HIPEC

Pancreatic Cancer – Risks, Pathology, and Treatment with HIPEC

by Combat Cancer | Aug 24, 2024 | News

Pancreatic adenocarcinoma is one of the most lethal forms of cancer. Its incidence is on the rise and, in many regions, it is predicted to become the second leading cause of cancer death in the coming decades. Unlike many other cancers, which have seen improvements in...
Combat Medical’s HIVEC-HEAT for Patients with BCG-Unresponsive Bladder Cancer Phase 3 Trial

Combat Medical’s HIVEC-HEAT for Patients with BCG-Unresponsive Bladder Cancer Phase 3 Trial

by Combat Cancer | Aug 16, 2024 | News

Bladder cancer is a formidable adversary, affecting thousands of people worldwide every year. In particular, patients with BCG-unresponsive bladder cancer face daunting treatment challenges. Historically, radical cystectomy has been the mainstay treatment when...
The Efficacy of Different Interventions in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer: Review and Meta-Analysis

The Efficacy of Different Interventions in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer: Review and Meta-Analysis

by Combat Cancer | Aug 10, 2024 | News

A recent systematic review and meta-analysis conducted by Rose et al., under the Société Internationale d’Urologie in 2022, investigated the efficacy of different interventions in recent trials that specifically included patients meeting the FDA’s...
Alcohol Consumption and Bladder Cancer – A Comprehensive Study from China

Alcohol Consumption and Bladder Cancer – A Comprehensive Study from China

by Combat Cancer | Aug 3, 2024 | News

An interesting study was undertaken in China and published online on 15th September 2021. The aim was to look at the potential link between alcohol consumption and bladder cancer risk, using various relevant studies from the past, which were searched for in several...

Recent Posts

  • Could Vitamin D Play a Role in the Prevention and Treatment of Colorectal Cancer?
  • AI-Powered OncoRedox Colorectal Cancer Sensor
  • “SampleCam” – Could This Tiny Robotic Device Be An Alternative To Invasive Colonoscopies For High-Risk Patients?
  • Genetics and Bowel Cancer Risk
  • Combat’s Upcoming HIVEC®-HEAT Study 2025

Recent Comments

    Archives

    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • July 2023
    • January 2023
    • December 2022
    • August 2022
    • May 2022
    • April 2022
    • March 2022

    Categories

    • Hyperthermia
    • News
    • The Medical Innovators Interview
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Stay informed about the COMBAT Group
    For more information contact: Combat Medical Group
    UK (+44) 1582 343 120 | Spain (+34) 910 46 89 71
    Privacy statement